CLAVIN A TYPE-1 RIBOSOME-INACTIVATING PROTEIN FROM ASPERGILLUS-CLAVATUS IFO-8605 - CDNA ISOLATION, HETEROLOGOUS EXPRESSION, BIOCHEMICAL ANDBIOLOGICAL CHARACTERIZATION OF THE RECOMBINANT PROTEIN
D. Parente et al., CLAVIN A TYPE-1 RIBOSOME-INACTIVATING PROTEIN FROM ASPERGILLUS-CLAVATUS IFO-8605 - CDNA ISOLATION, HETEROLOGOUS EXPRESSION, BIOCHEMICAL ANDBIOLOGICAL CHARACTERIZATION OF THE RECOMBINANT PROTEIN, European journal of biochemistry, 239(2), 1996, pp. 272-280
We describe the cloning and expression of a new cDNA from the filament
ous fungus Aspergillus clavatus IFO 8605. This cDNA contains an open r
eading frame (ORF) that predicts a putative ribonuclease precursor wit
h high similarity to the alpha-sarcin family of ribosome-inactivating
proteins (RIPs). The cDNA encoding the mature protein was expressed in
Escherichia coli, and the recombinant protein, a 17-kDa polypeptide d
esignated clavin was purified and characterized. Clavin shows typical
type-1 RIP properties: specific cleavage of ribosomal and synthetic RN
A and inhibition of protein synthesis in cell-free and cellular system
s. When selectively targeted to a tumour cell antigen by coupling to a
monoclonal antibody (mAb) clavin was able ro inhibit protein synthesi
s at nanomolar concentration. Pharmacokinetics analysis in mice indica
ted an elimination half-life ((t1/2 beta)) of 7.4 h with no particular
accumulation in major organs. Liver toxicity was very limited and tra
nsient while no alteration of kidney function was observed. Clavin ind
uced a late and very low antibody response in mice. The in vitro and i
n vivo biological characteristics of clavin, together with its availab
ility in large amounts, suggest the usefulness of this toxin in the pr
oduction of toxic chemical conjugates.